Host immune effector system

The host immune effector system is a complex network of cells, tissues, and soluble molecules that execute the body's defense against pathogens and abnormal self-cells, such as those found in cancer (StatPearls: Immune System, 2023). It comprises both innate components, like neutrophils and the complement system, and adaptive components, such as T-lymphocytes and B-lymphocytes, which provide specific and long-lasting protection (NIH: National Institute of Allergy and Infectious Diseases). In clinical pharmacology, this system is not a single molecular target but rather a functional entity modulated by various therapeutic classes. For instance, immune checkpoint inhibitors release the "brakes" on T-cells to treat malignancy, while immunosuppressive agents like corticosteroids or TNF inhibitors dampen overactive responses in autoimmune disorders (PubMed: PMC7151812). Understanding the balance of this system is critical, as overstimulation can lead to severe systemic inflammation or autoimmunity, while underactivity leaves the host vulnerable to life-threatening infections.

Other names

Immune systemEffector immune responseHost defense mechanismsImmune effector arm

Modulation of immune cell activity, including the activation of T-cells via checkpoint inhibition, suppression of inflammatory cytokines, or stimulation of innate immune pathways to eliminate pathogens or malignant cells (StatPearls: Immune Response, 2023; PubMed: PMC7151812).